NCT06640348View on ClinicalTrials.gov

Ultrasensitive SERS Platform With Highly Efficient Enrichment of Analyte for Screening and Diagnosis of Epithelial Ovarian Cancer

RecruitingOBSERVATIONAL

Enrollment

70

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2030

Conditions

Ovarian Cancer, Epithelial

Interventions

OTHER

No intervention

No intervention

Trial Locations (1)

Unknown

RECRUITING

Anhui Provincal Hospital, Hefei

All Listed Sponsors

lead

Anhui Provincial Hospital

OTHER_GOV